Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: szentecyclolabhu

March 30, 2026 CD derivatives

Arthur Lütringhaus, Godfather of catenanes was born 120 years ago

Professor Arthur Lütringhaus is the pioneer of the chemistry of interlocked supramolecular systems, that he named catenates. Arthur Lüttringhaus (1906-1992)

Continue reading

February 6, 2026 CD derivatives / Other industrial use

Blue Danube PhD Symposium – BDSHC 2026

On Friday, the 13th February at 13:30 CET a group of brilliant PhD students from the Blue Danube countries (A,CZ,H, SK,

Continue reading

February 5, 2026 Drug delivery / Pharma applications

Remdesivir (GS-5734) protects African green monkeys (AGM) from Nipah virus challenge

Introduction: Nipah virus is an emerging pathogen in the Paramyxoviridae family, which appers today a real threat for eventual pandemy.

Continue reading

January 9, 2026 CD as API / Pharma applications

Hydroxypropyl-Beta-Cyclodextrin (HPBCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics

A multi-year scientific collaboration between Brasilian and American scientists from Federal University at Rio de Janeiro, Brazil, Laboratory of Immunoregulation,

Continue reading

November 25, 2025 Drug delivery / Pharma applications

Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment

In a recent study, Professors Bodor and Buchwald review the use of cyclodextrin-enabled formulations to develop oral tablets of cladribine

Continue reading

October 13, 2025 CD as API / Pharma applications

JIC Venture Growth Investments Invests in Beren Therapeutics P.B.C. to Advance Innovative, Cyclodextrin-based Therapeutics

JIC Venture Growth Investments (VGI) announced that it has invested in Beren Therapeutics P.B.C. (“Beren Therapeutics”). Beren Therapeutics is developing

Continue reading

September 11, 2025 Drug delivery / Pharma applications

Multiple therapeutic benefits of Sulforaphane/alpha-cyclodextrin complex

Introduction: Sulforaphane (SFN) is a naturally occurring isothiocyanate (Fig.1) associated with various health benefits, including reduced cancer risk, and has

Continue reading

September 2, 2025 Drug delivery / Pharma applications

Selecting a non-interacting buffer for α-cyclodextrin containing solutions

The article examines the effects of twelve pharmaceutically relevant buffers on the inclusion complex between α-cyclodextrin (α-CD) and 1,9-nonanediol using

Continue reading

August 11, 2025 CD as API / Pharma applications

Sickle cell anemia and cyclodextrins

(The very first report on the beneficial consequence of cyclodextrin-assisted cholesterol removal from red blood cell membranes.) Sickle cell anemia

Continue reading

June 2, 2025 Drug delivery / Pharma applications

Does a Gut-Joint Axis exist? (Potential Role of bile acids and microbiome in Osteroarthritis treatment)

The gut-joint axis is a bidirectional communication and interaction between the gastrointestinal tract (gut) and the joints. It involves the

Continue reading

Posts pagination

1 2 3 … 7 Next Posts»

Recent Posts

  • Special issue: Novel macrocycles: from synthesis to supramolecular function
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer’s disease
  • Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems
  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (347)
  • CD derivatives (410)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (793)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (222)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (400)
  • Other industrial use (106)
  • Pharma applications (1,185)
  • Supramolecular systems (40)
  • Uncategorized (148)

Top Posts

  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease
  • Special issue: Novel macrocycles: from synthesis to supramolecular function
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems
  • Cyclodextrin-based delivery systems in parenteral formulations: A critical update review
  • Cyclodextrin Solubility: Can Green Solvents Be the Solution?
  • Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs
  • Effect of dimethyl-β-cyclodextrin on the interaction between Helicobacter pylori and steroidal compounds
  • Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs
  • MDPI—Nanomaterials Asia-Pacific Academic Forum 2020

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,473 other subscribers

Loading Comments...